Advertisement

Ads Placeholder
Loading...

Galapagos NV

GLPG.BR•EURONEXT
Healthcare
Biotechnology
€15.99
€0.00(0.00%)
U.S. Market opens in 56h 4m

Galapagos NV (GLPG.BR) Stock Overview

Explore Galapagos NV’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-3.70
EPS (TTM)N/A
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$15.99

GLPG.BR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Galapagos NV (GLPG.BR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $15.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.70 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

NaN
NaN
NaN, NaN, NaN, NaN

Company Facts

IPO DateMay 6, 2005
CountryNaN

Frequently Asked Questions